Biomarkers for heart failure

Yvan Devaux; Mélanie Vausort; Lu Zhang

Biomarkers for heart failure

Yvan Devaux (Inventor)
, Mélanie Vausort (Inventor)
, Lu Zhang (Inventor)

Cardiovascular Research Unit

Research output: Patent

Abstract

The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.

Original language	English
IPC	WO 2017/046203
Publication status	Published - 23 Mar 2017

Cite this

@misc{19a52b6bd449448aa9ec79214ea637e6,

title = "Biomarkers for heart failure",

abstract = "The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.",

author = "Yvan Devaux and M{\'e}lanie Vausort and Lu Zhang",

year = "2017",

month = mar,

day = "23",

language = "English",

type = "Patent",

note = "WO 2017/046203",

}

TY - PAT

T1 - Biomarkers for heart failure

AU - Devaux, Yvan

AU - Vausort, Mélanie

AU - Zhang, Lu

PY - 2017/3/23

Y1 - 2017/3/23

N2 - The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.

AB - The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.

M3 - Patent

ER -

Biomarkers for heart failure

Abstract

Fingerprint

Cite this